Literature DB >> 12891231

MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu-Natal, South Africa.

Paul K Chelule, Michelle Gordon, Thesla Palanee, Taryn Page, Anisa Mosam, H M Coovadia, Sharon Cassol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12891231     DOI： 10.1016/S0009-9236(03)00151-6

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.

Authors:  Elin Svensson; Jan-Stefan van der Walt; Karen I Barnes; Karen Cohen; Tamara Kredo; Alwin Huitema; Jean B Nachega; Mats O Karlsson; Paolo Denti
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

2.  The role of Multidrug Resistance-1 (MDR1) variants in response to atorvastatin among Jordanians.

Authors:  Karem H Alzoubi; Omar F Khabour; Sayer I Al-Azzam; Fadia Mayyas; Nizar M Mhaidat
Journal:  Cytotechnology       Date:  2014-01-11       Impact factor: 2.058

3.  Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users.

Authors:  Anu M Neuvonen; Jukka U Palo; Antti Sajantila
Journal:  Int J Legal Med       Date:  2011-02-11       Impact factor: 2.686

Review 4.  Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview.

Authors:  Pascal O Bessong; Nontokozo D Matume; Denis M Tebit
Journal:  AIDS Res Ther       Date:  2021-01-06       Impact factor: 2.250

5.  Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.

Authors:  Louise Warnich; Britt I Drögemöller; Michael S Pepper; Collet Dandara; Galen E B Wright
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.